首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   651篇
  免费   35篇
  国内免费   34篇
耳鼻咽喉   1篇
儿科学   19篇
妇产科学   6篇
基础医学   84篇
口腔科学   11篇
临床医学   86篇
内科学   89篇
皮肤病学   11篇
神经病学   37篇
特种医学   172篇
外科学   43篇
综合类   23篇
预防医学   77篇
眼科学   21篇
药学   19篇
中国医学   1篇
肿瘤学   20篇
  2022年   5篇
  2021年   4篇
  2019年   4篇
  2018年   14篇
  2017年   3篇
  2016年   5篇
  2015年   12篇
  2014年   15篇
  2013年   15篇
  2012年   14篇
  2011年   19篇
  2010年   26篇
  2009年   39篇
  2008年   28篇
  2007年   39篇
  2006年   36篇
  2005年   33篇
  2004年   16篇
  2003年   10篇
  2002年   22篇
  2001年   19篇
  2000年   9篇
  1999年   22篇
  1998年   28篇
  1997年   38篇
  1996年   20篇
  1995年   14篇
  1994年   11篇
  1993年   14篇
  1992年   12篇
  1991年   9篇
  1990年   10篇
  1989年   19篇
  1988年   22篇
  1987年   11篇
  1986年   13篇
  1985年   7篇
  1984年   8篇
  1983年   7篇
  1982年   6篇
  1981年   10篇
  1980年   6篇
  1979年   7篇
  1978年   4篇
  1977年   6篇
  1976年   3篇
  1975年   6篇
  1972年   4篇
  1968年   2篇
  1967年   4篇
排序方式: 共有720条查询结果,搜索用时 15 毫秒
71.
72.
Effect of flow on polymorphonuclear leukocyte/endothelial cell adhesion   总被引:24,自引:6,他引:24  
Lawrence  MB; McIntire  LV; Eskin  SG 《Blood》1987,70(5):1284-1290
The effect of flow on the adhesion of polymorphonuclear leukocytes (PMNL) to vascular endothelium was investigated using a parallel plate chamber with a well-defined flow field. Washed PMNL were perfused over a monolayer of primary human umbilical vein endothelial cells (HUVEC) pretreated with formyl-methionyl-leucyl-phenylalanine (FMLP, 1 X 10(-7) mol/L) for five minutes. In other experiments HUVEC were pretreated with interleukin 1 (IL1,2 U/mL) for four hours. PMNL adhesion to stimulated and control HUVEC was measured over a physiologic range of wall shear stresses. PMNL adhesion to nylon-coated surface was also studied. At a wall shear stress of 0.98 dynes/cm2,283 +/- 37.3 PMNL/mm2 (mean +/- SEM) adhered to FMLP-treated HUVEC while 195 +/- 20.3 PMNL/mm2 adhered to control HUVEC. At 1.96 dynes/cm2, 68 +/- 14.1 PMNL/mm2 adhered to FMLP-treated HUVEC and 42 +/- 6.0 PMNL/mm2 adhered to control HUVEC. At 3.92 dynes/cm2, virtually no PMNL adherence was noted on either control or FMLP-treated HUVEC. On IL 1-treated HUVEC at 1.96 dynes/cm2, 371 +/- 25.8 PMNL/mm2 adhered while 28 +/- 2.9 PMNL/mm2 adhered to control HUVEC. PMNL adhesion to IL 1-treated and control HUVEC dropped to 10.2 +/- 3.8 and 6.8 +/- 3.5 PMNL/mm2, respectively, at 3.01 dynes/cm2. The effect of flow on PMNL adhesion appears to be an important factor in determining the outcome of the PMNL/HUVEC adhesive interaction under these experimental conditions.  相似文献   
73.
Caldwell  J; Emerson  SG 《Blood》1995,86(9):3364-3372
To explore the biochemical and physiologic basis of the overlapping effects of interleukin-1 alpha (IL-1 alpha) and tumor necrosis factor alpha (TNF-alpha) on myeloid cytokine production, we have studied the dynamics of granulocyte colony-stimulating factor (G-CSF) and granulocyte-monocyte colony-stimulating factor (GM-CSF) production as well as IL-1 receptor and TNF receptor expression in a clonally derived bone marrow stromal cell strain (CDCL). IL-1 alpha and TNF alpha act in a synergistic manner to stimulate G-CSF and GM-CSF production by CDCL, resulting in an increase in CSF secretion that is 250-fold greater than that observed with either cytokine alone. This synergism in protein secretion is paralleled by synergistic increases the steady-state level of GM- and G-CSF mRNA, with supra-additive levels achieved by 24 hours. Coincident with this synergistic induction of myeloid CSFs, treatment of CDCL cells with IL-1 alpha induces a 300% increase in the expression of TNF receptors. IL-1 alpha induction of TNF receptors reaches a peak after 6 hours and gradually returns to baseline level by 24 hours. IL-1 alpha does not affect TNF receptor ligand binding affinity. A kinetic study comparing IL-1/TNF synergistic induction of growth factor secretion with IL-1 alpha induction of TNF receptors shows that these events occur in parallel. In contrast with the induction of TNF receptors by IL-1 alpha, treatment with TNF alpha has no effect on either the number of IL-1 receptors expressed by CDCL cells or IL-1 receptor ligand binding affinity. Brief treatment of IL-1 alpha/TNF alpha-stimulated CDCL cells with cycloheximide before receptor induction reduces the synergistic increase in growth factor mRNA by 40% to 60% compared with cells not treated with CHX. Taken together, these results raise the possibility that IL-1 alpha cross-induction of TNF receptors may contribute to the biochemical mechanisms underlying the synergistic stimulation of G-CSF and GM-CSF production by IL-1 alpha and TNF alpha.  相似文献   
74.
75.
Aim: In spite of several reports of an increased risk of sudden infant death syndrome (SIDS) in connection with bed‐sharing, it is not an uncommon practice. The aim of this study was to examine bed‐sharing at 6 months of age and the factors that are associated with bed‐sharing. Methods: Our cohort comprised 8176 randomly chosen families. At 6 month of age, the families received an invitation to the study, with a questionnaire, which was completed by 5605 families (response rate 68.5%). Results: Of the families, 19.8% bed‐shared. In the multivariate analysis, we found a correlation between breast‐feeding and bed‐sharing (breast‐feeding at 6 months: OR 1.94; 95% CI 1.56, 2.41). Moreover, we found an association with 3+ nightly awakenings at 6 months (2.70; 2.20, 3.32). It was more common to share a bed if the parent was single (2.04; 1.19, 3.51) and less common if the infant was bottle‐fed in the first week (0.70; 0.54, 0.90). Never using a pacifier was associated with a higher frequency of bed‐sharing. Conclusion: We found a correlation between breast‐feeding and bed‐sharing as well as between sleeping problems and a single parent. A lower percentage of infants sleeping in the parental bed were seen in association with formula feeding in the first week after birth.  相似文献   
76.
77.
78.
79.
SG Gotha 《MedR Medizinrecht》2006,24(8):497-502
Abstrakt 1. Für die Berechtigung der Krankenkasse zum Einbehalt der Anschubfinanzierung kommt es auf bereits geschlossene IV-Vertr?ge an. 2. Apotheken geh?ren nicht zu den nach § 140b SGB V zum Vertragsabschluss berechtigten Leistungserbringern. 3. Zum Sinn und Zweck einer Integrierten Versorgung. (Leits?tze des Bearbeiters)  相似文献   
80.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号